260 related articles for article (PubMed ID: 31979070)
21. Pretargeted PET of Osteodestructive Lesions in Dogs.
Maitz CA; Delaney S; Cook BE; Genady AR; Hoerres R; Kuchuk M; Makris G; Valliant JF; Sadeghi S; Lewis JS; Hennkens HM; Bryan JN; Zeglis BM
Mol Pharm; 2022 Sep; 19(9):3153-3162. PubMed ID: 35635337
[TBL] [Abstract][Full Text] [Related]
22. Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.
Houghton JL; Zeglis BM; Abdel-Atti D; Sawada R; Scholz WW; Lewis JS
J Nucl Med; 2016 Mar; 57(3):453-9. PubMed ID: 26471693
[TBL] [Abstract][Full Text] [Related]
23. Trans-cyclooctene tag with improved properties for tumor pretargeting with the diels-alder reaction.
Rossin R; van Duijnhoven SM; Läppchen T; van den Bosch SM; Robillard MS
Mol Pharm; 2014 Sep; 11(9):3090-6. PubMed ID: 25077373
[TBL] [Abstract][Full Text] [Related]
24. Diels-Alder reaction for tumor pretargeting: in vivo chemistry can boost tumor radiation dose compared with directly labeled antibody.
Rossin R; Läppchen T; van den Bosch SM; Laforest R; Robillard MS
J Nucl Med; 2013 Nov; 54(11):1989-95. PubMed ID: 24092936
[TBL] [Abstract][Full Text] [Related]
25. Harnessing
Keinänen O; Fung K; Brennan JM; Zia N; Harris M; van Dam E; Biggin C; Hedt A; Stoner J; Donnelly PS; Lewis JS; Zeglis BM
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28316-28327. PubMed ID: 33106429
[TBL] [Abstract][Full Text] [Related]
26. CD11b-Based Pre-Targeted SPECT/CT Imaging Allows for the Detection of Inflammation in Aortic Aneurysm.
Zhou X; Zhu K; Zhang Y; Ming Y; Shi D; Tan H; Xiang B; Zhu S; Cheng D; Lai H; Wang C; Liu G
J Inflamm Res; 2022; 15():1921-1933. PubMed ID: 35321320
[TBL] [Abstract][Full Text] [Related]
27. Development of a New Folate-Derived Ga-68-Based PET Imaging Agent.
Brand C; Longo VA; Groaning M; Weber WA; Reiner T
Mol Imaging Biol; 2017 Oct; 19(5):754-761. PubMed ID: 28194631
[TBL] [Abstract][Full Text] [Related]
28. Dual-Modality PET-SPECT Image-Guided Pretargeting Delivery in HER2(+) Breast Cancer Models.
Hapuarachchige S; Si G; Huang CT; Lesniak WG; Mease RC; Guo X; Gabrielson K; Artemov D
Biomacromolecules; 2021 Nov; 22(11):4606-4617. PubMed ID: 34704434
[TBL] [Abstract][Full Text] [Related]
29. Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry.
Houghton JL; Membreno R; Abdel-Atti D; Cunanan KM; Carlin S; Scholz WW; Zanzonico PB; Lewis JS; Zeglis BM
Mol Cancer Ther; 2017 Jan; 16(1):124-133. PubMed ID: 28062708
[TBL] [Abstract][Full Text] [Related]
30. Click-Mediated Pretargeted Radioimmunotherapy of Colorectal Carcinoma.
Membreno R; Cook BE; Fung K; Lewis JS; Zeglis BM
Mol Pharm; 2018 Apr; 15(4):1729-1734. PubMed ID: 29502416
[TBL] [Abstract][Full Text] [Related]
31. Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction.
Membreno R; Cook BE; Zeglis BM
J Vis Exp; 2019 Jan; (143):. PubMed ID: 30774125
[TBL] [Abstract][Full Text] [Related]
32. Inverse electron demand Diels-Alder click chemistry for pretargeted PET imaging and radioimmunotherapy.
Sarrett SM; Keinänen O; Dayts EJ; Dewaele-Le Roi G; Rodriguez C; Carnazza KE; Zeglis BM
Nat Protoc; 2021 Jul; 16(7):3348-3381. PubMed ID: 34127865
[TBL] [Abstract][Full Text] [Related]
33. Metal-Free Cycloaddition Chemistry Driven Pretargeted Radioimmunotherapy Using α-Particle Radiation.
Shah MA; Zhang X; Rossin R; Robillard MS; Fisher DR; Bueltmann T; Hoeben FJM; Quinn TP
Bioconjug Chem; 2017 Dec; 28(12):3007-3015. PubMed ID: 29129050
[TBL] [Abstract][Full Text] [Related]
34. Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging.
Mandikian D; Rafidi H; Adhikari P; Venkatraman P; Nazarova L; Fung G; Figueroa I; Ferl GZ; Ulufatu S; Ho J; McCaughey C; Lau J; Yu SF; Prabhu S; Sadowsky J; Boswell CA
MAbs; 2018; 10(8):1269-1280. PubMed ID: 30199303
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging.
Roosenburg S; Laverman P; Joosten L; Eek A; Rutjes FP; van Delft FL; Boerman OC
Mol Imaging; 2012; 11(5):401-7. PubMed ID: 22954184
[TBL] [Abstract][Full Text] [Related]
36. An Efficient Method for Labeling Single Domain Antibody Fragments with
Zhou Z; Devoogdt N; Zalutsky MR; Vaidyanathan G
Bioconjug Chem; 2018 Dec; 29(12):4090-4103. PubMed ID: 30384599
[TBL] [Abstract][Full Text] [Related]
37. Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate.
Cook BE; Adumeau P; Membreno R; Carnazza KE; Brand C; Reiner T; Agnew BJ; Lewis JS; Zeglis BM
Bioconjug Chem; 2016 Aug; 27(8):1789-95. PubMed ID: 27356886
[TBL] [Abstract][Full Text] [Related]
38. Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [
Lumen D; Vugts D; Chomet M; Imlimthan S; Sarparanta M; Vos R; Schreurs M; Verlaan M; Lang PA; Hippeläinen E; Beaino W; Windhorst AD; Airaksinen AJ
Bioconjug Chem; 2022 May; 33(5):956-968. PubMed ID: 35442642
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of (68)Ga- and (177)Lu-DOTA-PEG4-LLP2A for VLA-4-Targeted PET Imaging and Treatment of Metastatic Melanoma.
Beaino W; Nedrow JR; Anderson CJ
Mol Pharm; 2015 Jun; 12(6):1929-38. PubMed ID: 25919487
[TBL] [Abstract][Full Text] [Related]
40. In Vivo Pretargeting Based on Cysteine-Selective Antibody Modification with IEDDA Bioorthogonal Handles for Click Chemistry.
Ferreira VFC; Oliveira BL; D'Onofrio A; Farinha CM; Gano L; Paulo A; Bernardes GJL; Mendes F
Bioconjug Chem; 2021 Jan; 32(1):121-132. PubMed ID: 33295756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]